Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-422 Cr₹818 Cr₹794 Cr₹3,977 Cr

What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA is ₹-422 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-422 Cr
Mar2023₹818 Cr
Mar2022₹794 Cr
Mar2021₹3,977 Cr

How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-422 Cr
Negative
Mar2023 ₹818 Cr
2.97
Mar2022 ₹794 Cr
-80.03
Mar2021 ₹3,977 Cr -

Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹27,374.9 Cr 0.4% -0.4% 39.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,549.0 Cr -2% -8.4% 14.3% Stock Analytics
DIVIS LABORATORIES ₹175,673.0 Cr -0.2% 7.5% 48% Stock Analytics
CIPLA ₹118,908.0 Cr -0.3% -2.6% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,106.0 Cr -1% -4.1% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,494.0 Cr 0.3% 8% 6.2% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.4%

-0.4%

39.9%

SENSEX

-0.4%

0.3%

8.7%


You may also like the below Video Courses